Use of a PD-1 checkpoint inhibitor in a patient with ultra-high-risk gestational trophoblastic neoplasia and gastrointestinal metastases

Gestational trophoblastic neoplasia (GTN) are rare diseases that are typically chemo-responsive. While the majority of patients are cured with chemotherapy alone, a small portion of cases are fatal due to chemotherapy resistance. Risk factors for treatment failure are liver and brain metastases, ext...

وصف كامل

التفاصيل البيبلوغرافية

الحاوية / القاعدة:	Gynecologic Oncology Reports
المؤلفون الرئيسيون:	Amalia Brawley, Casey Moffitt, Shaina Feldman Bruce, Caitlin Stashwick Farabaugh, Edward Podczaski, Joel Sorosky
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Elsevier 2024-12-01
الموضوعات:	Choriocarcinoma Gestational trophoblastic neoplasia Immunotherapy Pembrolizumab
الوصول للمادة أونلاين:	http://www.sciencedirect.com/science/article/pii/S2352578924002091